2. 2
• Over 6 Years of field experience (FDA & CE cleared)
• Installed in hospitals around the world
• Over 300,000 patients monitored to date
• Exceptionally effective R&D team – many “world firsts”
• Integrated into Welch Allyn monitors and the Philips
Intellivue
• Extensive clinical studies
3. Reduced Adverse Events
3
1. Brown, HV et al, The American Journal of Medicine. 2014; 127: 226-232 2. Palace, ZJ et al, AGS. May 2013 3. Zimlichman, et al, ATS. 2012
45%
Reduction in the
number of ICU days
on patients
transferred from
med/surg1
9%
Reduction in Length
of Stay1
86%
Reduction in the
number of Code Blue
events1
43%
Reduction in the
number of Patient
Falls2
64%
Reduction in the
number of Pressure
Ulcers1
Based on a 7,643 Patient Clinical Trial
7. 7
Respiratory RateHeart Rate
Continuous monitoring provides
earlier intervention and improved
clinical and financial results
Taenzer AH et al. Anesthesiology 2011:115
8.
9. 9
The return on investment of implementing a continuous
monitoring system in general medical-surgical units
1. Allman RM, eat al. Pressure ulcers, hospital complications, and disease severity: impact on hospital costs and length of stay. Adv Wound Care. 1999.
2. Milbrandt EB, et al. Growth of intensive care unit resource use and its estimated cost in Medicare. Crit Care Med. 2008. Health Care Utilization Project (HCUP), Nationwide Inpatient Sample (NIS), Agency for
Healthcare Research and Quality, 2008
Model
Analysis
Consideration
Savings Per
Patient
Admission
Annual
Savings
Base Case Total cost of intervention effects $710 $1,701,600
Conservative
Includes only direct variable cost
Component of final day of LOS
$224 $537,400
Slight, SP et al, Society of General Internal Medicine. 2013
Assuming 33 beds, 2,500 Patients per Unit per Year
10. 10
Join us to deliver improved outcomes via
contact-free sensing & continuous monitoring!
Visit us @ BES Healthcare’s Booth, #128
Notas do Editor
EarlySense is bringing its product to market in the medical space based on 3 value propositions that are critically important to hospitals and long term care institutions: 1. Improved clinical outcomes, 2. Improved economic outcomes, 3. Marketing benefit for institutions using the EarlySense system. This slide and the next 2 show these 3 value propositions.
Avner: can we add mortality?
This technology was developed over a decade of research based on very large data sets collected by EarlySense. In addition to the current abilities to measure accurately and with few false alarms EarlySense developed smart, predictive analytics capabilities and is working on a future breakthrough of measuring blood pressure in a contact free way. Many of the advanced analytics capabilities as well as the blood pressure measurement is protected by issued US Patents.
EarlySense know not only how to develop hardware and algorithms but also to provide and implement solution and prove their effectiveness as shown in some of the next slides
This technology was developed over a decade of research based on very large data sets collected by EarlySense. In addition to the current abilities to measure accurately and with few false alarms EarlySense developed smart, predictive analytics capabilities and is working on a future breakthrough of measuring blood pressure in a contact free way. Many of the advanced analytics capabilities as well as the blood pressure measurement is protected by issued US Patents.
EarlySense know not only how to develop hardware and algorithms but also to provide and implement solution and prove their effectiveness as shown in some of the next slides
This technology was developed over a decade of research based on very large data sets collected by EarlySense. In addition to the current abilities to measure accurately and with few false alarms EarlySense developed smart, predictive analytics capabilities and is working on a future breakthrough of measuring blood pressure in a contact free way. Many of the advanced analytics capabilities as well as the blood pressure measurement is protected by issued US Patents.
EarlySense know not only how to develop hardware and algorithms but also to provide and implement solution and prove their effectiveness as shown in some of the next slides
This technology was developed over a decade of research based on very large data sets collected by EarlySense. In addition to the current abilities to measure accurately and with few false alarms EarlySense developed smart, predictive analytics capabilities and is working on a future breakthrough of measuring blood pressure in a contact free way. Many of the advanced analytics capabilities as well as the blood pressure measurement is protected by issued US Patents.
EarlySense know not only how to develop hardware and algorithms but also to provide and implement solution and prove their effectiveness as shown in some of the next slides
Respiratory Rate & Heart Rate are proven to be most effective early indicators of deterioration
Most deteriorations in hospitals have early warning signs 6-8 hours prior to deterioration
Early detection leads to early intervention Saves lives (70%) & reduces costs (38%)
EarlySense system helps hospitals save money. This was proven by a clinical study led by Harvard professors and published in a peer reviewed scientific journal.